Penn Center for Innovation

Penn establishes center to accelerate coronavirus research

Posted on March 25, 2020 — Jessica Jones Gupta

The Perelman School of Medicine at the University of Pennsylvania has established a new center to help expand and accelerate research related to the novel coronavirus, SARS-CoV-2, that causes the respiratory illness known as COVID-19. The Center of Research for Coronaviruses and Other Emerging Pathogens aims to advance research to better understand the pathology of the coronavirus and, ultimately,…

Calling on all Life Sciences and Other Organizaons to Donate Supplies to Fight COVID-19

Posted on March 23, 2020 — Jessica Jones Gupta

Our friends at Life Sciences PA have put out a call for all Life Sciences and other organizations to donate supplies to fight COVID-19 that have been identified by PA: “Attached via this link is a list of supplies and scientific and medical expertise we have collectively identified as most needed at this time. We ask you…

Philadelphia COVID-19 Small Business Relief Fund

Posted on — Jessica Jones Gupta

The Philadelphia COVID-19 Small Business Relief Fund offers grants or zero-interest loans to Philadelphia small businesses impacted by the COVID-19 pandemic. The program, administered by the Department of Commerce and Philadelphia Industrial Development Corporation (PIDC), aims to: Provide relief to small businesses in order to help them survive this crisis. Retain as many employees as possible. Help businesses…

How these Philly startups are faring (or pivoting) amid COVID-19

Posted on March 19, 2020 — Jessica Jones Gupta

“This has forced us to think critically about our business model to see how we can emerge through dire market conditions,” said Adit Gupta, cofounder of VyB, an app for rating businesses IRL.  The article also features Simply Good Jars and NeuroFlow. Read more on Technical.ly Philly

Big pharma shied away from gene therapy for years. Academia picked up the slack

Posted on March 18, 2020 — Jessica Jones Gupta

When big pharma backed away from gene therapy, academia transformed tech transfer to advance the science. “The old way is, ‘I have a patent, I’m going to throw it over the fence to you and you throw me a sack of money,’” said John Swartley, managing director of the University of Pennsylvania’s Penn Center for…

Amicus opens UCity R&D tower, calls Philly the ‘Cradle of Cures’

Posted on March 10, 2020 — Jessica Jones Gupta

Amicus Therapeutics, a publicly traded biopharmaceutical firm focused on rare diseases, has moved nearly 100 R&D professionals over the past year into 3675 Market St., in Philadelphia’s University City, and plans to add another 100. “Here in Philadelphia is where we are going to do all our science,” says John Crowley, chief executive of Amicus,…

NextUp: Carisma Therapeutics is engineering white blood cells to kill cancer

Posted on — Jessica Jones Gupta

The company wants to be the first to engineer a macrophage, a parasite-eating white blood cell found in humans, to destroy cancer tumors. Read more on Philadelphia Magazine’s NextUp Column

A Penn Engineering professor’s take on what the women behind the ENIAC would think of today’s tech

Posted on March 9, 2020 — Jessica Jones Gupta

The six women who programmed the first computer will represent Pennovation Works at Philly Tech Week 2020 presented by Comcast. Read more on Technical.ly Philly

Electric motor startup IQ Motion Control hopes Philly becomes a hub for robotics

Posted on — Jessica Jones Gupta

The startup, run by a pair of cousins at the Pennovation Center, is hiring additional team members after grabbing seed funding from Gabriel Investments. Read More on Technical.ly Philly

2nd IPO this year by a Philadelphia-area life sciences company, and the 5th since late October, is expected this week

Posted on February 27, 2020 — Jessica Jones Gupta

Passage Bio, a Philadelphia gene therapy startup spun out of the University of Pennsylvania, is set to go public Friday. The company plans to sell 7.4 million shares of its common stock at between $16 and $18 per share, according to documents it filed with the Securities and Exchange Commission. Read more on the Philadelphia…